Saturday, May 14, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Emerging nanomaterials-based biosensor for SARS-CoV-2 detection

by Medical Finance
in Coronavirus
Study: Smart and emerging nanomaterials-based biosensor for SARS-CoV-2 detection. Image Credit: Nhemz/Shutterstock
9
SHARES
101
VIEWS
Share on FacebookShare on Twitter

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) belongs to the Coronaviridae family. These viruses contain a single non-segmented, single-stranded ribonucleic acid (ssRNA) genome of vertebrates.

The RNA virus can be detected through real-time polymerase chain reaction (RT-PCR) techniques; a major drawback of this technique is the longer time required for detection.

Study: Smart and emerging nanomaterials-based biosensor for SARS-CoV-2 detection. Image Credit: Nhemz/ShutterstockStudy: Smart and emerging nanomaterials-based biosensor for SARS-CoV-2 detection. Image Credit: Nhemz/Shutterstock


Recently, many aspects of the RT-PCR technique have been modified to make it highly specific towards the SARS-CoV-2 virus—by determining its specific targets. Nevertheless, there lies an immediate necessity for new, rapid and economical methods for the detection of SARS-CoV-2.

Biosensors have added advantages for identifying RNA-viruses by utilizing aptamer-conjugated nanoparticles, Au-Ag-based nanoparticles, CRISPR-Cas9 based paper strip and surface plasmon resonance electrochemical biosensors and shows promise in serving as a portable tool for diagnosing SARS-CoV-2.

A new review published in the Materials Letters aimed to highlight the different smart and emerging nanomaterials used to detect SARS-CoV-2.

The present article also discussed current diagnostic strategies, biomarkers and future perspectives of smart and emerging nanomaterials for the fabrication of biosensors.

Background

Previous data suggest that enormous biomarkers can be used for SARS-CoV-2 detection. Numerous biomarkers of various viruses – like middle east respiratory syndrome (MERS) and influenza virus, harbor special primers and may be fully expressed by RT-PCR assays. These have high sensitivity towards SARS-CoV-2 detection.

The four structural proteins, namely – matrix (M), spike (S), nucleocapsid (N) and envelope (E), are used as antigens in the diagnosis of SARS-CoV-2. Tests for specific antibodies are also useful in the detection of SARS-CoV-2. These antibodies develop naturally from the adaptive immune response of infected patients through the process known as active immunity. Antibodies bind to the S protein and neutralize the infectious capacity of the virus and also prohibit disease progression through impeding the viral interaction with the angiotensin-converting enzyme 2 (ACE2) receptors.

Antibodies may also develop against the spike proteins – this process is known as “passive immunity.” S proteins enzyme-linked immunosorbent assay (ELISA) can be used to measure the antibodies against SARS-CoV-2.

Biosensors can serve as alternative tools for biomarker detection of antibodies against SARS-CoV-2, as they offer high accuracy, rapid response, enhanced sensitivity, portability and selectivity. Furthermore, these methods are less technique-sensitive and provide knowledge regarding the infection’s critical trends and severity.

Latest nanomaterial developments

Latest smart nanomaterials that are in use for biosensing applications of SARS-CoV-2 infection are – metal oxides, carbon-based nanomaterials, transition metal dichalcogenide, quantum dots, polymer-based nanocomposites, among others. Unique properties of these nanomaterials and their composites for biosensors fabrication are – small size, signal generation, quenching and signal amplification.

Among the metal nanoparticles, the biosensing of virus infections is majorly done by gold nanoparticles. The advantages include – biocompatibility, enhanced loading capacity of bio-analyte and electrocatalytic properties. Gold nanoparticles could detect the antigen within 30 mins from human samples, and the obtained results were in complete agreement with WHO guidelines. Further, when polystyrene nanoparticles doped with lanthanide were used to detect the anti-SARS-CoV-2 IgG in human serum, the obtained results were comparable to those of the RT-PCR technique.

Graphene is an excellent nanomaterial; a field-effect transistor (FET)-based biosensor was fabricated using a coating of graphene sheet, for detecting specific antibodies. Meanwhile, field-effect Au-decorated graphene nanosensors were also developed to quickly identify the SARS-CoV-2 virus. In addition, an immunosensor was developed using the combination of graphene-FET with antigen-antibody interaction for real-time detection of the SARS-CoV-2 spike protein. Graphene and its derivatives, owing to their high conductivity and good biocompatibility, are deemed essential candidates for advanced biosensing applications for point of care tests (POCT).

Carbon nanotubes (CNTs) – made from graphene sheets, show outstanding mechanical, electronic and thermal properties. These were used for developing a rapid identification system using a near-infrared mechanism. Inactivation of the virus was also tried through inhibition surfaces with single-walled CNTs decorated with metals for adsorption of H2O2. CNTs overcome drawbacks of graphene-based sensors, such as carrier migration.

Transition metal dichalcogenides (TMDCs) are emerging as excellent materials for biosensing. They possess optical, electronic, mechanical and magnetic properties and render large bandgaps and better signal strength. Among these, molybdenum disulfide (MoS2) offers a fast electron transfer rate, superior conductivity and feasibility, along with biocompatibility and stability.

Quantum dots are tiny semiconductor nanocrystals that can convert light spectrum into various colors. They show excellent fluorescence, quantum confinement and tunable band energy. These have proven to be novel fluorescent probes for molecular imaging. Additionally, carbon-based quantum dots have been identified as an efficient virus-inactivation agent. Besides, graphitic carbon nitride-cadmium sulfide quantum dot nanocomposites could determine SARS-CoV-2 receptor-binding domain (RBD). Furthermore, they can be used to label the virus’s envelope, while novel fluorescent-based quantum dots may aid in developing advanced diagnostic methods.

Molecularly imprinted polymers (MIPs) have been used to detect multiple viruses. They are promising as future sensor technology, as these could be cost-effective, environmental-friendly, rapid, sensitive, selective and specific.

Screen-printed electrodes (SPE) are easily modified with nanomaterials and confer better electroanalytical performances and sensitivity. Screen-printed graphene electrodes (SPGE) show superior electrochemical properties to other electrode-based materials.

Conclusion

In summary, smart and emerging nano-based materials have become essential components of biomedical sciences. Nanomaterials offer adsorption, high surface area and high reactivity and serve as excellent biosensors. Biosensors can serve as powerful analytical tools that can provide a detailed understanding of critical trends and conditions severity of SARS-CoV-2 and can help in early and rapid diagnosis of the infection.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern. Image Credit: CKA/Shutterstock

Novel fusion inhibitor blocks SARS-CoV-2 spike-mediated cell-cell fusion

by Medical Finance
May 13, 2022
0

In a recent study published in the journal Viruses, researchers constructed a novel fusion inhibitor−based recombinant protein, referred to as...

Study: PROmotion of COvid-19 VA(X)ccination in the Emergency Department – PROCOVAXED: Study Protocol for a Cluster Randomized Controlled Trial. Image Credit: WESTOCK PRODUCTIONS / Shutterstock.com

Promoting COVID vaccination in emergency departments

by Medical Finance
May 13, 2022
0

Although effective vaccines providing short-term protection against coronavirus disease 2019 (COVID-19) were developed at a record-breaking speed, there remains significant...

Study: More severe pneumonitis in children predicts the need for admission and elevation of some but not all markers of severe Covid-19. Image Credit: Pixel-Shot/Shutterstock

The significance of bedside lung ultrasound on predicting COVID-19-related hospitalization in children

by Medical Finance
May 13, 2022
0

A recent study posted to the medRxiv* preprint server demonstrated the significance of bedside lung ultrasound on predicting coronavirus disease 2019 (COVID-19)-related...

Study: Mosaic RBD nanoparticles protect against multiple sarbecovirus challenges in animal models. Image Credit: SciePro/Shutterstock

Mosaic-8 RBD-nanoparticles show promise as a vaccine candidate for SARS-CoV-2 and potential sarbecoviruses spillovers

by Medical Finance
May 13, 2022
0

In a recent study posted to the bioRxiv* preprint server, researchers designed nanoparticles representing receptor-binding domains (RBDs) of the spike...

Study: Cardiac impairment in Long Covid 1-year post-SARS-CoV-2 infection. Image Credit: Kateryna Kon/Shutterstock

Study explores incidence of cardiac impairment a year after SARS-CoV-2 infection

by Medical Finance
May 13, 2022
0

In a recent study posted to the medRxiv* pre-print server, researchers used cardiac magnetic resonance (CMR) to show the one-year...

Study: Reporting Rates for VAERS Death Reports Following COVID-19 Vaccination, December 14, 2020-November 17, 2021. Image Credit: Anze Furlan / Shutterstock

CDC/FDA reports on VAERS – no association between vaccines and increased mortality

by Medical Finance
May 13, 2022
0

Although vaccinations have been administered against global coronavirus disease 2019 (COVID-19), many people are still hesitant to receive vaccinations. Concerns...

Next Post
Mayo Clinic researchers report differences in genomic data quality among racial groups

Mayo Clinic researchers report differences in genomic data quality among racial groups

Study: Predictors for Early and Late Death in Adult Patients with COVID-19: A Cohort Study. Image Credit: shutter_o/Shutterstock

Researchers evaluate predictors for mortality in hospitalized COVID-19 patients

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • bacteria Sebastian Kaulitzki 46826fb7971649bfaca04a9b4cef3309 620x480
    Study finds higher levels of germs inside cars than the average toilet
  • Study: Vitamin D Supplements for Prevention of Covid-19 or other Acute Respiratory Infections: a Phase 3 Randomized Controlled Trial (CORONAVIT). Image Credit: Alrandir/Shutterstock
    Effectiveness of a ‘test-and-treat’ approach for identification and treatment of vitamin D insufficiency for prevention of COVID-19
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply